血促肾上腺皮质激素及皮质醇水平与抑郁发作患者自杀风险的临床研究

doi:10.3760/cma.j.cn441417-20240619-05018

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (5): 792-795.DOI: 10.3760/cma.j.cn441417-20240619-05018

血促肾上腺皮质激素及皮质醇水平与抑郁发作患者自杀风险的临床研究

杨茂增¹ 蔡伟玲² 陆小兵³ 梁耀国⁴ 李一凡⁵ 梁苑施⁵

¹东莞市第七人民医院老年精神科，东莞 523220；²东莞市第七人民医院睡眠医学科，东莞 523220；³东莞市第七人民医院成人精神科，东莞 523220；⁴东莞市第七人民医院医疗救治科，东莞 523220；⁵东莞市第七人民医院检验科，东莞 523220

收稿日期:2024-06-19 出版日期:2025-03-01 发布日期:2025-03-14
通讯作者: 杨茂增，Email：289148905@qq.com
基金资助:
广州市科技局重点研发计划（202206010090）；东莞市社会科技发展一般项目（20221800904662）

Research on the relationships between blood adrenocorticotropic hormone and cortisol levels and suicide risk in patients with depressive episodes

Yang Maozeng¹, Cai Weiling², Lu Xiaobing³, Liang Yaoguo⁴, Li Yifan⁵, Liang Yuanshi⁵

¹Psychiatry Department for the Elderly, Dongguan Seventh People's Hospital, Dongguan 523220, China; ²Department of Sleep Medicine, Dongguan Seventh People's Hospital, Dongguan 523220, China; ³Psychiatry Department for Adults, Dongguan Seventh People's Hospital, Dongguan 523220, China; ⁴Department of Medical Treatment and Rescue, Dongguan Seventh People's Hospital, Dongguan 523220, China; ⁵Laboratory Medicine Department, Dongguan Seventh People's Hospital, Dongguan 523220, China

Received:2024-06-19 Online:2025-03-01 Published:2025-03-14
Contact: Yang Maozeng, Email: 289148905@qq.com
Supported by:
Key Research and Development Plan of Guangzhou Science and Technology Bureau (202206010090); Dongguan City Social Science and Technology Development General Project (20221800904662)

摘要/Abstract

摘要：

目的　探讨血促肾上腺皮质激素（ACTH）及皮质醇（COR）水平与抑郁发作患者自杀风险的关系，为早期识别和干预抑郁发作患者自杀行为提供临床依据。方法　选取东莞市第七人民医院2022年8月至2024年5月就诊的80例抑郁发作患者为研究对象，采用病例对照研究设计，应用Beck自杀意念量表对患者进行自杀风险评估，并采取外周血测定ACTH及COR水平。其中，40例自杀意念评分阳性患者为研究组，40例自杀意念评分阴性患者为对照组。研究组：男20例、女20例，年龄19～65（42.87±2.98）岁，病程1～10（5.87±0.56）年。对照组：男21例、女19例，年龄19～64（42.84±2.97）岁，病程1～11（5.89±0.59）年。两组采用相同方法治疗6周。比较治疗前后两组ACTH水平、COR水平、汉密尔顿抑郁量表（HAMD）评分、Beck评分。统计学方法采用t检验。结果　治疗前，研究组患者ACTH与COR水平均高于对照组［（25.41±11.84）ng/L比（20.14±7.45）ng/L、（268.41±66.52）nmol/L比（239.25±57.41）nmol/L］，差异均有统计学意义（t=2.38、2.10，均P<0.05）；抗抑郁治疗后，研究组ACTH水平、COR水平、HAMD评分、Beck评分均高于对照组（t=6.05、12.88、14.36、38.11，均P<0.05）。结论　抑郁发作患者ACTH及COR水平越高，自杀风险就越高，且在抗抑郁治疗后ACTH及COR水平仍然高于无自杀风险患者，血ACTH及COR水平可作为评估抑郁发作患者自杀风险的潜在生物学指标。

关键词:

抑郁发作, 自杀风险, 促肾上腺皮质激素, 皮质醇, 病例对照研究

Abstract:

Objective　To explore the relationships between the levels of adrenocorticotropic hormone (ACTH) and cortisol (COR) and the suicide risk in patients with depressive episodes, and to provide clinical evidences for early identification and intervention of suicidal behaviors in patients with depressive episodes. Methods　In this study, 80 patients aged 18 - 65 years who were diagnosed with depressive episodes and visited Dongguan Seventh People's Hospital from August 2022 to May 2024 were selected as the research objects. A case-control study design was adopted. The Beck Scale for Suicide Ideation was used to assess the patients' suicide risk, and peripheral blood was collected to measure the levels of ACTH and COR. Among them, 40 patients with positive score on the suicide ideation scale were included in the study group, while 40 patients with negative score on the suicide ideation scale were included in the control group. There were 20 males and 20 females in the study group, aged 19-65 (42.87±2.98) years, and the course of disease was 1-10 (5.87±0.56) years. There were 21 males and 19 females in the control group, aged 19-64 (42.84±2.97) years, and the course of disease was 1-11 (5.89±0.59) years. The two groups received the same treatment. The ACTH level, COR level, Hamilton Depression Rating Scale (HAMD) score, and Beck score were compared between the two groups before and after treatment. t test was used for statistical analysis. Results　Before treatment, the ACTH and COR levels in the study group were higher than those in the control group [(25.41±11.84) ng/L vs. (20.14±7.45) ng/L, (268.41±66.52) nmol/L vs. (239.25±57.41) nmol/L], with statistically significant differences (t=2.38 and 2.10, both P<0.05). After antidepressant treatment, the ACTH level, COR level, HAMD score, and Beck score in the study group were higher than those in the control group (t=6.05,12.88,14.36 , and 38.11, all P<0.05). Conclusions　Among patients with depressive episodes, the higher the levels of ACTH and COR are, the higher the suicide risk is. Moreover, after antidepressant treatment, the levels of ACTH and COR are still higher than those in patients without suicide risk, suggesting that the blood levels of ACTH and COR may be potential biological indicators for assessing the suicide risk in patients with depressive episodes.

Key words:

Depressive episodes, Suicide risk, Adrenocorticotropic hormone, Cortisol, Case-control study

杨茂增蔡伟玲陆小兵梁耀国李一凡梁苑施.

血促肾上腺皮质激素及皮质醇水平与抑郁发作患者自杀风险的临床研究 [J]. 国际医药卫生导报, 2025, 31(5): 792-795.

Yang Maozeng, Cai Weiling, Lu Xiaobing, Liang Yaoguo, Li Yifan, Liang Yuanshi.

Research on the relationships between blood adrenocorticotropic hormone and cortisol levels and suicide risk in patients with depressive episodes [J]. International Medicine and Health Guidance News, 2025, 31(5): 792-795.

参考文献

[1] 王臻,黄奇,相福芹,等. 经颅直流电刺激联合米氮平治疗产后抑郁症患者的效果及对临床症状ACTH与孤啡肽水平的影响[J]. 中国妇幼保健,2024,39(8):1403-1406. DOI:10.19829/j.zgfybj.issn.1001-4411.2024.08.012.
[2] 罗静伊,洪刚,任小群. 基于社会心理风险因素构建预测青少年抑郁症病人自杀的风险预测模型[J]. 全科护理,2024,22(23):4366-4370. DOI:10.12104/j.issn.1674-4748. 2024.23.003.
[3] 洪玲. 抑郁症患者自杀风险现状及其相关影响因素分析[J]. 黑龙江医学,2024,48(18):2194-2196. DOI:10.3969/j.issn.1004-5775.2024.18.005.
[4] 王燕,海洋. 反刍思维与安全感在青少年抑郁症患者冲动性人格和自杀风险间的链式中介作用[J]. 护理学杂志,2024,39(17):93-96. DOI:10.3870/j.issn.1001-4152.2024. 17.093.
[5] 谭兴艳,朱颖爽,金海英,等. 基于回归分析法构建青少年抑郁症患者自残自杀风险预警模型[J]. 临床护理杂志,2024,23(4):39-43. DOI:10.3969/j.issn.1671-8933.2024.04.011.
[6] Turecki G, Brent DA, Gunnell D, et al. Suicide and suicide risk[J]. Nat Rev Dis Primers, 2019 ,5(1):74.DOI: 10.1038/s41572-019-0121-0.
[7] 王媛媛,甘建光,陈晶,等. 失效模式与效应分析风险管理在住院抑郁症患者自杀预防中的应用[J]. 中华全科医学,2024,22(4):633-637. DOI:10.16766/j.cnki.issn.1674- 4152.003468.
[8] 庞连东,王新月,段春杰. 度洛西汀治疗伴不同程度焦虑症状的抑郁症临床疗效比较[J]. 中国药物与临床,2024,24(6):390-394. DOI:10.11655/zgywylc2024.06.010.
[9] 甄文凤,周娇娇,杨婧,等. 不同性别老年抑郁症患者血脂水平与自杀风险的关系[J]. 神经疾病与精神卫生,2024,24(3):165-170. DOI:10.3969/j.issn.1009-6574.2024.03.003.
[10] 罗传琳,李媛媛,刘肇瑞,等. 精神分裂症、抑郁症、双相障碍患者自杀风险比较及相关因素[J]. 中国心理卫生杂志,2024,38(1):1-8. DOI:10.3969/j.issn.1000-6729.2024. 01.001.
[11] 曹颖,刘建萍,王晓玲,等. 心理ICU治疗模式应用于抑郁症患者的效果分析[J]. 黑龙江医学,2023,47(21):2579-2582. DOI:10.3969/j.issn.1004-5775.2023.21.005.
[12] 朱文佳,徐淑敏,张霞.自杀风险评估分层护理干预抑郁症患者的效果[J].慢性病学杂志,2023,24(10):1571-1573. DOI: 10.16440/J.CNKI.1674-8166.2023.10.36.
[13] 范雪菲,马亚荣,邱允,等. 抑郁症患者睡眠结构与自杀风险的相关性分析[J]. 国际精神病学杂志,2023,50(4):719-722.
[14] 李岳朋,尚正君,周红丽,等. 分级预防策略对门诊抑郁症患者自杀风险的影响[J]. 心理月刊,2023,18(5):105-107. DOI:10.19738/j.cnki.psy.2023.05.032.
[15] 吴乔,申璎,刘小军,等. 加味逍遥散联合氟伏沙明对青少年抑郁症的疗效分析[J]. 今日药学,2023,33(5):373-375. DOI:10.12048/j.issn.1674-229X.2023.05.010.
[16] 康延海,盛莉. 老年首发抑郁症患者自杀风险影响因素[J]. 中国老年学杂志,2022,42(5):1201-1204. DOI:10.3969/j.issn.1005-9202.2022.05.051.
[17] 吴琪,王宝安,化振,等. 抑郁症新兵自杀风险因素的临床研究[J]. 职业与健康,2022,38(3):362-367.
[18] 鲁新儒,黄悦勤,李明慧,等. 中国社区成人抑郁症临床症状亚型与功能残疾的关系[J]. 中国心理卫生杂志,2021,35(12):977-984. DOI:10.3969/j.issn.1000-6729.2021. 12.001.
[19] 温淑媛,毛忠珍,李海燕,等. 自杀风险评估的分层护理对住院抑郁症患者自杀行为的影响[J]. 中国现代医生,2021,59(30):160-163.
[20] 戴春晓,高力舒,张海生,等. 具有自杀倾向的抑郁症患者睡眠脑电图特点[J]. 中国现代医生,2021,59(29):117-121.
[21] 高莹. 积极心理暗示对抑郁症患者希望水平及自杀风险的影响[J]. 心理月刊,2020,15(10):45-46. DOI:10.19738/j.cnki.psy.2020.10.028.
[22] 辛立敏,陈林,杨甫德,等. 伴忧郁特征的抑郁症患者自杀风险因素分析[J]. 临床精神医学杂志,2020,30(1):1-4. DOI:10.3969/j.issn.1005-3220.2020.01.001.
[23] 张立刚,乞盟,魏艳艳,等. 首发未治疗抑郁症患者自杀风险与情感气质的关系[J]. 中国神经精神疾病杂志,2019,45(12):729-733. DOI:10.3969/j.issn.1002-0152.2019. 12.006.
[24] 李莹珊,宁玉萍. 伴与不伴激越症状重度抑郁患者的住院自杀风险[J]. 临床精神医学杂志,2019,29(6):400-402. DOI:10.3969/j.issn.1005-3220.2019.06.013.
[25] 刘国友,宋君伟,张文佳,等. 康复技能训练对抑郁症患者病情及自杀风险的作用[J]. 世界最新医学信息文摘,2019,19(94):7-9. DOI:10.19613/j.cnki.1671- 3141.2019.94.004.
[26] 陈美玲,梁艳宁,关素芳,等. 整体护理预案干预老年抑郁症患者自杀倾向的有效性分析[J]. 中国医药科学,2019,9(13):62-65. DOI:10.3969/j.issn.2095-0616.2019.13.018.
[27] 王海燕. 综合护理干预对降低抑郁症患者自杀风险的效果分析[J/CD]. 实用临床护理学电子杂志,2019,4(22):18-19.
[28] 陈刚,马莹,居丽晶,等. 自杀风险评估分层护理干预对新入院抑郁症患者自杀行为的影响观察[J]. 临床医学工程,2019,26(5):677-678. DOI:10.3969/j.issn.1674-4659. 2019.05.0677.
[29] 何新华,何英杰. 自杀风险评估的分层护理干预对住院抑郁症患者自杀行为的影响[J]. 系统医学,2019,4(3):162-164. DOI:10.19368/j.cnki.2096-1782.2019.03.162.
[30] 陈彬彬,吕海燕,徐象珍. 抑郁症患者自杀风险与下丘脑-垂体-肾上腺轴功能的研究[J]. 中国卫生标准管理,2019,10(1):35-37. DOI:10.3969/j.issn.1674-9316.2019.01.016.

血促肾上腺皮质激素及皮质醇水平与抑郁发作患者自杀风险的临床研究

Research on the relationships between blood adrenocorticotropic hormone and cortisol levels and suicide risk in patients with depressive episodes

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

[1]	段昆梅尚茜张红梅. 肺癌幸存者癌因性疲乏的特征及其与焦虑抑郁和应激相关激素的相关性研究 [J]. 国际医药卫生导报, 2025, 31(1): 132-135.
[2]	沈慧玲江剑民何艳冰梁薇李小晶吴汶霖. B超辅助定位在婴儿痉挛症患儿行ACTH肌内注射中的效果 [J]. 国际医药卫生导报, 2023, 29(23): 3483-3486.
[3]	何伟军, 熊喜悦, 娄明星, 彭颖, 王益超. 孤独症谱系障碍儿童血清激素水平对照研究[J]. 国际医药卫生导报, 2022, 28(12): 1699-1703.
[4]	张小芳魏玉磊. 17-OHP、ATCH联合血清睾酮在CAH新生儿早期筛查中的应用[J]. 国际医药卫生导报, 2022, 28(1): 53-56.
[5]	蔡文仙, 孙广斐, 郑钦亮, 李秋波. 促肾上腺皮质激素对婴儿痉挛症患儿淋巴细胞亚群和免疫球蛋白的影响[J]. 国际医药卫生导报, 2021, 27(6): 837-839.